[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
[ Tue, May 17th 2022 ]: WOPRAI
Neena Bitritto-Garg Maintained (ATAI) at Strong Buy with Decreased Target to $22 on, May 17th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Neena Bitritto-Garg of Citigroup, Maintained "Atai Life Sciences N.V." (ATAI) at Strong Buy with Decreased Target from $26 to $22 on, May 17th, 2022.
Neena has made no other calls on ATAI in the last 4 months.
There is 1 other peer that has a rating on ATAI. Out of the 1 peers that are also analyzing ATAI, all agrees with Neena's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $9 on, Thursday, March 31st, 2022